Nephron & Sharps collaborate to develop best manufacturing practices

Date: 2022-11-12   Author: Saipriya Iyer  Category: #news

Nephron & Sharps collaborate to develop best manufacturing practices

Pharmaceutical firm, Nephron Pharmaceuticals Corporation and renowned medical device and pharmaceutical packaging company, Sharps Technology, Inc. have recently entered a partnership.

With this collaboration, both firms look forward to developing and sharing best practices in innovative manufacturing, customer support, product development, and quality as Nephron looks forward to unveiling the InjectEZ component of expansion.

For the unversed, InjectEZ falls under the hundreds of millions of dollars of investment made by Nephron for expanding in Lexington County, S.C., over the last two years.

Not to mention, Nephron CEO Lou Kennedy addressed that partnerships are crucial for launching an ambitious endeavor, such as InjectEZ.

Speaking on the latest move, Kennedy mentioned that the firm is thrilled to collaborate with Sharps Technology, as the InjectEZ project opens, for several innovative initiatives, including R&D (research and development).

Kennedy also highlighted that Sharps Technology offers critical solutions to overcome healthcare challenges as the InjectEZ syringe manufacturing facility will play a pivotal role in assisting those with whom the firm collaborates to tackle the rising public health crises.

Kennedy further stated that the firm is looking forward to working with Sharps Technology.

Apparently, Sharps product lines have typically concentrated on low-waste and ultra-low-waste syringe technologies, which incorporate multiple passive safety features while permitting around 40% more injections per vial of therapy. These features safeguard the public and front-line healthcare workers against potentially fatal needle stick injuries.

With the new collaboration, Nephron will provide several prospects to Sharps for proliferating its portfolio and impacting the specially designed pre-fillable syringe and drug delivery systems market.

Sources further reveal that the products that will be developed and commercialized will offer solutions to support the overall Nephron fill/finish strategies along with their pipeline of new drug applications.

It also sets a strategy to back advanced therapies and branded pharma, including ophthalmic and biologic applications.

Source credit -

About Author

Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

India-based Kaizen AI set to influence the $1.36 trillion GCC realty sector

Author: Pankaj Singh

Kaizen AI, a prominent technology firm that uses AI to revolutionize large-scale building projects, is entering the lucrative GCC real estate sector, where the value of planned and under-construction projects is projec...

Microsoft expands partnership with Oracle to Deliver Oracle Database Services

Author: Pankaj Singh

Microsoft Corp. and Oracle Corp. have reportedly announced the availability of Oracle Database@Azure, which provides direct access to the Oracle database services operating on Oracle Cloud Infrastructure ...

Reliance Industries and NVIDIA join hands to advance AI in India

Author: Pankaj Singh

Indian billionaire Mukesh Ambani-owned Reliance Industries Ltd. has reportedly announced a partnership with U.S.-based chipmaker NVIDIA for advancing AI in India.

Apparently, Indi...